1. GPCR/G Protein
  2. Adenosine Receptor
  3. Adenosine receptor antagonist 7

Adenosine receptor antagonist 7 是一种具有口服活性的三重 A1/A2A/A2B 腺苷受体拮抗剂,其 Ki 值分别为 1.5、0.6 和 21 nM。Adenosine receptor antagonist 7 在 A2AR-HEK293 细胞中对环磷酸腺苷 (cAMP) 的产生具有强效抑制活性 (IC50 值为 0.8 nM)。Adenosine receptor antagonist 7 与 Avelumab (HY-108730) 联合使用时,可增强效应 T 细胞的浸润,并提高 CD8+/Treg的比例。Adenosine receptor antagonist 7 可用于癌症研究,如结肠癌。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

Adenosine receptor antagonist 7

Adenosine receptor antagonist 7 Chemical Structure

CAS No. : 2570904-69-5

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Adenosine receptor antagonist 7 is an orally active triple A1/A2A/A2B adenosine receptor antagonist with Ki values of 1.5, 0.6 and 21 nM. Adenosine receptor antagonist 7 shows potent inhibitory activity (IC50 = 0.8 nM) of cAMP production in A2AR-HEK293 cells. Adenosine receptor antagonist 7 can enhance infiltration of effector T cells and increase the CD8+/Treg ratio companied with Avelumab (HY-108730). Adenosine receptor antagonist 7can be used for the research of cancer, such as colon cancer[1].

IC50 & Target[1]

A1

1.5 nM (Ki)

A2A

0.6 nM (Ki)

A2B

21 nM (Ki)

体外研究
(In Vitro)

Adenosine receptor antagonist 7 (Compound 14a) (0.32-1000 nM, 30 mins) 可抑制人 CD8+T 细胞中 NECA (HY-103173) 诱导的 cAMP 积累 (IC50 = 18 nM)[1]。br> Adenosine receptor antagonist 7 (10-100 nM, 30 mins) 可抑制 A1R 过表达的 SK-BR-3 细胞中 ERKJNK 的磷酸化,下调 MMP-2MMP-9mRNA 表达[1]。br>

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: A1R-overexpressing SK-BR-3 cells
Concentration: 10 and 100 nM
Incubation Time: 30 mins
Result: Reduced the phosphorylation of ERK and JNK.
体内研究
(In Vivo)

Adenosine receptor antagonist 7 (Compound 14a) (50 mg/kg,口服,每天两次,持续 14 天) 可抑制携带 CT26 肿瘤的 BALB/c 裸鼠的肿瘤生长[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BALB/c nude mice bearing CT26 tumors[1]
Dosage: 50 mg/kg
Administration: Orally administration, twice a day for 14 days
Result: Inhibited tumor growth without adverse reactions such as weight loss.
Increased the number of tumor-infiltrating effector T cells and improved the CD8+/Treg ratio when combined with Avelumab.
分子量

390.44

Formula

C21H22N6O2

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Adenosine receptor antagonist 7
目录号:
HY-179248
需求量: